Clinical Study

Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia

Table 2

Positivity of immunohistochemical targets within the stroma.

NEDREC
<5%>5%<5%>5%Fisher exactPhi

CD4+3 (13.6%)19 (86.4%)12 (100%)0 (0%)<0.0001−0.83
CD8+13 (59.1%)9 (40.9%)10 (83.3%)2 (16.7%)n.s.−0.25
T-bet+3 (13.6%)19 (86.4%)12 (100%)0 (0%)<0.0001−0.83
GATA3+14 (63.6%)8 (36.4%)7 (83.3%)5 (41.7%)n.s.0.05
CD11c+4 (18.2%)18 (81.8%)10 (83.3%)2 (16.7%)0.0001−0.63

NED: not evidence of disease; REC: recurrence of disease.